StockData
BEATWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BEAT

HeartBeam, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.02+0.02 (+551.61%)

Close on Oct 19, 2026

Market cap
$1.07M
P/E (TTM)
–
Dividend yield
–

About HeartBeam

Surgical & Medical Instruments & Apparatus, SIC 3841

HeartBeam is a medical technology company that develops ambulatory cardiac monitoring solutions designed for use outside clinical environments. The company's primary offering is the HeartBeam System, a cable-free cardiac monitoring platform comprising a credit-card-sized three-dimensional electrocardiogram (ECG) recording device, a patient mobile application, cloud-based algorithms, and a web-based physician portal. The system records electrical signals from the heart across three dimensions to synthesize twelve-lead ECG readings for remote arrhythmia assessment, supported by continuous access to on-demand cardiologists. Target customers include concierge physicians, preventive cardiology practices, and hospital cardiology departments.

The company operates primarily within the United States, targeting initial commercialization through select cardiology practices and direct sales channels, while exploring potential international expansion opportunities. HeartBeam employed 16 personnel as of late 2025, expanding to 17 staff members in early 2026. The provided text does not disclose the company's specific headquarters location.

Summary of the business section of HeartBeam's latest annual report, written by StockData.

Company profile

Company

Legal name
HeartBeam, Inc.
Headquarters
Santa Clara, CA
Address
2118 Walsh Ave., Suite 210 95050
Phone
(408) 899-4443
Employees
16, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Marcum LLP, Morristown, New Jersey

Stock & identifiers

Ticker
BEATW
Other tickers
BEAT
Exchange
Nasdaq
Shares outstanding
56M, Aug 11, 2026
Public float
$36.37M, Jun 30, 2025
Filer category
<br>Emerging growth company
SEC CIK
1779372
CUSIP
42238H116
ISIN
US42238H1169
EIN
47-4881450

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Branislav VajdicPresident, Director3,970,784
Tim CruickshankCFO239,990
Kenneth Harry PersenChief Technology Officer448,290
Robert Paul ENOPresident36,742
Richard FerrariDirector352,289
Michael R. JaffDirector127,059
Marga Ortigas-WedekindDirector154,117
Mark E. StromeDirector3,707,146
Willem ElfrinkDirector645,492
Kenneth Warwick Nelson IIIDirector144,388
Urioste George deDirector0

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 16 employees.”

Corporate history

Events identified from SEC filings